Back to Agenda
Session 4: Pharmacovigilance
Session Chair(s)
Petar Mas
Clinical pharmacology specialist, Agency for Medicinal Products and Medical Devices of the Republic of Croatia, Croatia
Sabina Polimac Šuman
Patient Safety Lead /LSR, Roche, Bosnia and Herzegovina
Izabela Majic
Chief Operating Officer, QP, IBS-Experts International d.o.o., Croatia
This session will tackle Pharmacovigilance strategies and critical role of risk minimisation measures in ensuring medicine safety. Explore the intricacies of signal detection methodologies and navigate through regulatory challenges concerning the implementation of drug traceability monitoring for enhanced patient care and regulatory compliance in Bosnia and Herzegovina.
Speaker(s)
Pharmacovigilance in Serbia: Opportunities and Challenges
Regulatory Assessor, Medicines and Medical Devices Agency of Serbia , Serbia
Regulatory Challenges in the Implementation of Drug Traceability Monitoring in Bosnia and Herzegovina
Head of Pharmacovigilance and Materiovigilance Sector, ALMBiH, Bosnia and Herzegovina
Risk Minimisation Measures: which and when?
Head of Pharmacovigilance and Rational Pharmacotherapy Department, Agency for Medicinal Products And Medical Devices of Croatia (HALMED), Croatia
Project Smart Pharmacist – The Importance of Education in Pharmacovigilance
, CInMED, Montenegro
With Additional Participation of:
, Macedonian Agency for Medicines and Medical Equipment (MALMED), North Macedonia
Have an account?